Futura Medical Regulatory News (FUM)

17 Jul 2006 07:00

Futura Medical PLC17 July 2006 For immediate release 17 July 2006 Futura Medical plc Announces FLD500 scale-up trials Futura Medical plc (AIM: FUM) the pharmaceutical and medical device group thatdevelops innovative products for the sexual health market, announces pilotscale-up trials of its Female Lubrication Device (FLD500) ahead of dossiersubmission for the product's regulatory approval. A successful outcome of these trials will facilitate the submission to EUregulators during the first quarter of 2007 for FLD500's marketingauthorisation. FLD500 is a standard DurexTM 'easy on' condom with a thin elastomer coatingcontaining an active compound on the outer surface to promote greater naturallubrication and heightened pleasure for women. Currently up to 40% of condomssold within the UK are bought by women. Following encouraging initial stability and compatibility results on the productin laboratory studies, SSL International plc, the consumer healthcare brandscompany that manufactures and distributes DurexTM, will be conducting trialsthis month. James Barder, Chief Executive of Futura, said: "This is an important steptowards the submission of the regulatory dossier for FLD500 and will be thefirst condom product targeted to improve the sex lives of women." For further information: Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk Media enquiries:Buchanan CommunicationsMark Court Tel: +44 (0) 20 7466 5000 Notes Futura Medical plc Futura Medical is a pharmaceutical drug and medical device group developinginnovative products for the sexual health market. The Company is developing aportfolio of products and its strategy is to license their manufacture anddistribution to major pharmaceutical and healthcare groups. Futura's primaryfocus is on over-the-counter products with particular appeal to men and womenwho are reluctant to discuss potentially embarrassing sexual matters with theirdoctors. Futura is based in Guildford, Surrey, and its shares trade on the AIM market ofthe London Stock Exchange. For further details please visit www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange